Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway

Endocrinology

Volumn 153, Issue 11, 2012, Pages 5143-5149

  Goldberg, Ira J ^a   Huang, Li Shin ^a   Huggins, Lesley A ^a   Yu, Shuiqing ^a   Nagareddy, Prabhakara R ^a   Scanlan, Thomas S ^b   Ehrenkranz, Joel R ^c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CHOLESTEROL; DIIODOTHYRONINE; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MESSENGER RNA; SCAVENGER RECEPTOR BI; THYROID HORMONE; THYROXINE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; GENE EXPRESSION; HORMONE ACTION; HORMONE BLOOD LEVEL; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

ANIMALS; APOLIPOPROTEINS B; CHOLESTEROL; DIIODOTHYRONINES; LIVER; MICE; MICE, KNOCKOUT; RECEPTORS, LDL; SCAVENGER RECEPTORS, CLASS B; THYROXINE; TRIIODOTHYRONINE;

EID: 84867761220     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1572     Document Type: Article

References (30)

1. Mason RL, Hunt HM, Hurzthal L 1930 Blood cholesterol values in hyperthyroidism and hypothyroidism-their significance. N Engl J Med 26:1273-1278
2. Pramfalk C, Pedrelli M, Parini P 2011 Role of thyroid receptor β in lipid metabolism. Biochim Biophys Acta 1812:929-937
3. Faber J, Kirkegaard C, Lumholtz IB, Siersbaek-Nielsen K, Friis T 1982 Simultaneous measurement of 3,5-diiodothyronine and 3,5,3′- triiodothyronine turnover kinetics in euthyroid hyperthyroid, and hypothyroid subjects. J Clin Endocrinol Metab 55:8-12 (Pubitemid 13250316)
4. McClure J, De Mowbray RR, Gilliland IC 1961 The effect of 3:5-diiodo-D-thyronine on serum cholesterol. J Endocrinol 22:87-93
5. 2). Biochemistry (Mosc) 70:164-172
6. Angelin B, Rudling M 2010 Lipid lowering with thyroid hormone and thyromimetics. Curr Opin Lipidol 21:499-506
7. Liu YY, Brent GA 2010 Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation. Trends Endocrinol Metab 21:166-173
8. Shin DJ, Osborne TF 2003 Thyroid hormone regulation and cholesterol metabolism are connected through sterol regulatory element-binding protein-2 (SREBP-2). J Biol Chem 278:34114-34118 (Pubitemid 37553251)
9. Scheiffele E, Schultze KW 1972 The coronary drug project. JAMA 221:918
10. Ladenson PW, Kristensen JD, Ridgway EC, Olsson AG, Carlsson B, Klein I, Baxter JD, Angelin B 2010 Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. N Engl J Med 362:906-916
11. Johansson L, Rudling M, Scanlan TS, Lundåsen T, Webb P, Baxter J, Angelin B, Parini P 2005 Selective thyroid receptor modulation by GC-1reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice. Proc Natl Acad Sci USA 102:10297-10302 (Pubitemid 41024974)
12. Tancevski I, Demetz E, Eller P, Duwensee K, Hoefer J, Heim C, Stanzl U, Wehinger A, Auer K, Karer R, Huber J, Schgoer W, Van Eck M, Vanhoutte J, Fievet C, Stellaard F, Rudling M, Patsch JR, Ritsch A 2010 The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in mice. PLoS One 5:e8722
13. Goldberg IJ, Hu Y, Noh HL, Wei J, Huggins LA, Rackmill MG, Hamai H, Reid BN, Blaner WS, Huang LS 2008 Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes. Diabetes 57:1674-1682
14. Voyiaziakis E, Ko C, O'Rourke SM, Huang LS 1999 Genetic control of hepatic apoB-100 secretion in human apoB transgenic mouse strains. J Lipid Res 40:2004-2012 (Pubitemid 29523427)
15. Moreno M, Silvestri E, De Matteis R, de Lange P, Lombardi A, Glinni D, Senese R, Cioffi F, Salzano AM, Scaloni A, Lanni A, Goglia F 2011 3,5-Diiodo-L-thyronine prevents high-fat-diet-induced insulin resistance in rat skeletal muscle through metabolic and structural adaptations. FASEB J 25:3312-3324
16. Davidson NO, Carlos RC, Drewek MJ, Parmer TG 1988 Apolipoprotein gene expression in the rat is regulated in a tissue-specific manner by thyroid hormone. J Lipid Res 29:1511-1522 (Pubitemid 19013045)
17. Davidson NO, Carlos RC, Lukaszewicz AM 1990 Apolipoprotein B mRNA editing is modulated by thyroid hormone analogs but not growth hormone administration in the rat. Mol Endocrinol 4:779-785
18. Lanni A, Moreno M, Lombardi A, de Lange P, Silvestri E, Ragni M, Farina P, Baccari GC, Fallahi P, Antonelli A, Goglia F 2005 3,5-diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats. FASEB J 19:1552-1554 (Pubitemid 41279028)
19. Out R, Kruijt JK, Rensen PC, Hildebrand RB, de Vos P, Van Eck M, Van Berkel TJ 2004 Scavenger receptor BI plays a role in facilitating chylomicron metabolism. J Biol Chem 279:18401-18406 (Pubitemid 38623256)
20. Out R, Hoekstra M, de Jager SC, de Vos P, van der Westhuyzen DR, Webb NR, Van Eck M, Biessen EA, Van Berkel TJ 2005 Adenovirus-mediated hepatic overexpression of scavenger receptor class B type I accelerates chylomicron metabolism in C57BL/6J mice. J Lipid Res 46:1172-1181 (Pubitemid 43109832)
21. Lopez D, Abisambra Socarrás JF, Bedi M, Ness GC 2007 Activation of the hepatic LDL receptor promoter by thyroid hormone. Biochim Biophys Acta 1771:1216-1225 (Pubitemid 47404963)
22. Dolphin PJ, Forsyth SJ 1983 Nascent hepatic lipoproteins in hypothyroid rats. J Lipid Res 24:541-551 (Pubitemid 13059190)
23. Nikkilä EA, Kekki M 1972 Plasma triglyceride metabolism in thyroid disease. J Clin Invest 51:2103-2114
24. Ito M, Takamatsu J, Matsuo T, Kameoka K, Kubota S, Fukata S, Tamai H, Miyauchi A, Kuma K, Hanafusa T 2003 Serum concentrations of remnant-like particles in hypothyroid patients before and after thyroxine replacement. Clin Endocrinol (Oxf) 58:621-626 (Pubitemid 36566805)
25. Claudel T, Inoue Y, Barbier O, Duran-Sandoval D, Kosykh V, Fruchart J, Fruchart JC, Gonzalez FJ, Staels B 2003 Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. Gastroenterology 125:544-555 (Pubitemid 36929436)
26. Gullberg H, Rudling M, Saltó C, Forrest D, Angelin B, Vennström B 2002 Requirement for thyroid hormone receptor β in T3 regulation of cholesterol metabolism in mice. Mol Endocrinol 16:1767-1777 (Pubitemid 34828087)
27. Spady DK, Cuthbert JA, Willard MN, Meidell RS 1998 Overexpression of cholesterol 7α-hydroxylase (CYP7A) in mice lacking the low density lipoprotein (LDL) receptor gene. LDL transport and plasma LDL concentrations are reduced. J Biol Chem 273:126-132 (Pubitemid 28042185)
28. Naoumova RP, Neuwirth C, Lee P, Miller JP, Taylor KG, Soutar AK 2004 Autosomal recessive hypercholesterolaemia: long-term follow up and response to treatment. Atherosclerosis 174:165-172 (Pubitemid 38595453)
29. Kawagishi N, Satoh K, Akamatsu Y, Sekiguchi S, Ishigaki Y, Oikawa S, Satomi S 2007 Long-term outcome after living donor liver transplantation for two cases of homozygous familial hypercholesterolemia from a heterozygous donor. J Atheroscler Thromb 14:94-98
30. Venero CV, Thompson PD 2009 Managing statin myopathy. Endocrinol Metab Clin North Am 38:121-136